Figures speak for themselves: a staggering 4.5 million people in Europe have focal epilepsy. Most patients with epilepsy are taking at least one medication, but for 30 percent of the patients, drugs alone don’t seem to help, or they are experiencing severe side effects. Brain surgery is another treatment option, but only 1 percent of patients are candidates for that. Even fewer accept this option, as having parts of your brain removed can be – understandably – quite scary. When epileptic patients stand at the crossroads, where drugs have failed to provide a cure, innovative efforts of Precisis opens a new doorway. “We offer our help to the 30 percent of the drug-resistant patients,” says Dr. Angela Liedler, CEO of Precisis.
Description Precisis has built a technology aimed at improving the lives of patients who have epilepsy and other brain diseases. Precisis offers individualized and precise treatment methods in the field of neurostimulation that focuses on cortex stimulation procedure. Their innovation platform EASEE® or Epicranial Application of Stimulation Electrodes to Ease brain symptoms is suitable for individuals with epilepsy for whom medication no longer works or undergoing brain resection is out of the question. EASEE® can also be set up to target other brain diseases such as cognitive dysfunction, depression and rehabilitation after stroke.EASEE® offers a precise, individualized, and personalized stimulation through an easy surgical procedure.
This content is copyright protected
However, if you would like to share the information in this article, you may use the link below: